Patents by Inventor Hans-Peter Buchstaller

Hans-Peter Buchstaller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6492384
    Abstract: The invention relates to novel compounds of formula (I), wherein R, R1, R2, R3, n and p have the meaning defined in claim 1. Compounds are inhibitors of clotting factor Xa and can be used for the prophylaxis and/or therapy of thrombo-embolic disorders.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: December 10, 2002
    Assignee: Merck Patent GmbH
    Inventors: Werner Mederski, Horst Juraszyk, Hanns Wurziger, Joachim Gante, Dieter Dorsch, Hans-Peter Buchstaller, Sabine Bernotat-Danielowski, Guido Melzer, Soheila Anzali
  • Patent number: 6380430
    Abstract: Novel compounds of the formula I in which X, R1, R2, R3, R4 and R5 have the meaning indicated in Patent Claim 1, are inhibitors of the coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic disorders.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: April 30, 2002
    Assignee: Merck Patent Gesellschaft mit beschraenkterHaftung
    Inventors: Dieter Dorsch, Horst Juraszyk, Werner Mederski, Joachim Gante, Hanns Wurziger, Hans-Peter Buchstaller, Sabine Bernotat-Danielowski, Guido Melzer
  • Patent number: 5602144
    Abstract: Thienopyridone derivatives of the formula I ##STR1## in which B is CH or N, ##STR2## is ##STR3## R is H, ##STR4## R.sup.1, R.sup.2 and R.sup.5 are in each case H, A or Hal, R.sup.3 and R.sup.4 are in each case H, A, OH, OA, Hal, CF.sub.3 , NO.sub.2, NH.sub.2, NHA, N(A).sub.2 or NHAc,R.sup.6 is H or Hal,X is --CH.sub.2 --, --CO--, --O--, --NH--, --NA-- or --S--,A bis alkyl having 1-4 carbon atoms,Ac is alkanoyl having 1-6 carbon atoms, or benzoyl andHal is F, Cl, Br or I,and their salts, exhibit a high affinity for binding sites of amino acid receptors and are therefore suitable for treating neurodegenerative diseases.
    Type: Grant
    Filed: December 14, 1995
    Date of Patent: February 11, 1997
    Assignee: Merck Patent Gesellschaft mit Beschrankter Haftung
    Inventors: Rudolf Gottschlich, Joachim Leibrock, Christian Noe, Michael Berger, Hans-Peter Buchstaller